tiprankstipranks
Trending News
More News >
Fusion Antibodies Plc (GB:FAB)
:FAB
UK Market
Advertisement

Fusion Antibodies Plc (FAB) Price & Analysis

Compare
6 Followers

FAB Stock Chart & Stats


Fusion Antibodies Plc News

FAB FAQ

What was Fusion Antibodies Plc’s price range in the past 12 months?
Fusion Antibodies Plc lowest share price was 2.80p and its highest was 12.50p in the past 12 months.
    What is Fusion Antibodies Plc’s market cap?
    Fusion Antibodies Plc’s market cap is £12.22M.
      When is Fusion Antibodies Plc’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Fusion Antibodies Plc’s earnings last quarter?
      Currently, no data Available
      Is Fusion Antibodies Plc overvalued?
      According to Wall Street analysts Fusion Antibodies Plc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Fusion Antibodies Plc pay dividends?
        Fusion Antibodies Plc does not currently pay dividends.
        What is Fusion Antibodies Plc’s EPS estimate?
        Fusion Antibodies Plc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Fusion Antibodies Plc have?
        Fusion Antibodies Plc has 113,656,250 shares outstanding.
          What happened to Fusion Antibodies Plc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Fusion Antibodies Plc?
          Currently, no hedge funds are holding shares in GB:FAB

          Company Description

          Fusion Antibodies Plc

          Fusion Antibodies Plc (FAB) is a UK-based biotechnology company that specializes in the discovery, engineering, and supply of antibodies for therapeutic and diagnostic applications. Operating primarily in the biotechnology and pharmaceutical sectors, the company provides a range of antibody services including antibody humanization, production, and characterization. Fusion Antibodies leverages its expertise to assist in the development of innovative treatments and diagnostic solutions, supporting clients from early discovery through to clinical trials.

          Fusion Antibodies Plc (FAB) Earnings & Revenues

          Currently, no data available
          Please return soon. This page is being updated.
          Similar Stocks
          Company
          Price & Change
          Follow
          IXICO plc
          Oxford BioDynamics
          HemoGenyx Pharmaceuticals Plc
          ValiRx plc
          Aptamer Group Plc

          Ownership Overview

          5.97%94.03%
          Mutual Funds
          ― Other Institutional Investors
          94.03% Public Companies and
          Individual Investors

          Options Prices

          Currently, No data available
          ---
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis